Amplify Weight Loss Drug & Treatment ETF
THNR
Closed
$25.96
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
THNR was created on 2024-05-21 by Amplify. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 4.24m in AUM and 22 holdings. THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses.
Company
Amplify
Asset class
Equity
Inception date
2024
Investment segment
Health Care
ISIN
US0321085328
Website
Key stats
Open
$26.55
Volume
243.00
AUM
$4.54M
Prev. close
$26.24
Expense ratio
0.59%
P/E
17.19
$25.90
Day’s Range
$26.55
$23.40
52W Range
$27.25
What’s in the fund
2
Total sectors
Health Care
83.71%
Others
16.29%
Returns
Performance
_
Difference
_
Amplify Weight Loss Drug & Treatment ETF
Dec
31
Dividends
The last payment date was Dec 31, 2025
Div. per Share
$0.41
Div. Yield
1.57%
Div. Growth YoY
87.89%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply